Biologics vs Small Molecules: Key Considerations in Drug Development
How the body absorbs, distributes, metabolizes, and excretes a drug – differs significantly between the two modalities.
How the body absorbs, distributes, metabolizes, and excretes a drug – differs significantly between the two modalities.
Discover how CDMO services support Finished Dosage Form (FDF) development, from formulation to manufacturing and regulatory compliance.
We’re delighted to announce that we’ve won the Business Expansion award in the Integrated Manufacturing category at the 2025 Pharmaceutical Technology Excellence Awards.
Discover why project management is the critical success factor for CDMO collaborations. Explore Upperton’s approach.
Nikki Whitfield, CEO of Upperton, has received the ‘CEO Excellence in Pharmaceutical Manufacturing’ Award at the CEO Today Global Awards 2025
Explore the key differences between Finished Dosage Forms (FDFs) and APIs in drug development and manufacturing.
We’re delighted to share that Upperton has officially been accredited as on of the Sunday Time Best Places to Work 2025
We’re delighted to announce that Upperton has officially been accredited as one of The Sunday Times Best Places to Work 2025
Our Approach Project Initiation and Onboarding We typically initiate projects within two to three weeks of proposal acceptance. During this time, we manage project onboarding and procure any necessary materials. Our analytical team plays a crucial role in onboarding new methods, confirming their suitability, and ensuring readiness for the subsequent stages of your project. This … Read more
Upperton continues growth with appointment of Michael Mellor-Clark as Chief Commercial Officer.